International Biotechnology Trust PLC Nektar Therapeutics Transaction History

International Biotechnology Trust PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$4.16 - $13.72 $278,720 - $919,240	-67,000 Closed	0 $0
Q1 2020 May 18, 2020	SELL	$14.47 - $27.96 $1.06 Million - $2.04 Million	-73,000 Reduced 52.14%	67,000 $1.19 Million
Q4 2019 May 18, 2020	BUY	$15.87 - $23.12 $1.27 Million - $1.85 Million	80,000 Added 133.33%	140,000 $3.02 Million
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $1.83 Million - $3.4 Million	60,000 New	60,000 $1.55 Million
Q1 2018 May 15, 2018	SELL	$57.4 - $108.44 $12.1 Million - $22.9 Million	-211,000 Closed	0 $0

Q4 2017 Mar 02, 2018	BUY	$23.02 - $60.5 $4.86 Million - $12.8 Million	211,000 New	211,000 $12.6 Million
Q2 2017 Mar 02, 2018	SELL	N/A	-60,000 Closed	0 $0
Q4 2016 Mar 02, 2018	BUY	N/A	60,000	60,000 $736,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.